Clinically Relevant Drug Product Specifications: Methods of Establishment
Preclinical Development: Overview
Clinical Trials: Overview
Combination Therapies and Personalized Medicine
Targeted Cancer Therapies
Treatment Resistant Cancers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 11, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Nenad Medic1, Dina Filipenko2, Monica Hadi2
1BioPharmaceuticals R&D, Patient Centered Science, AstraZeneca, Cambridge, UK.
This study introduces a patient-centered real-world evidence (PCRWE) framework for oncology. It ensures patient perspectives are integrated into oncology product development, enhancing RWE generation.
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: